About Biotime

Established in April 2008, Xiamen Biotime is a hi-tech enterprise that specialized in R&D, production, and sales of POCT in vitro diagnostic devices and reagents. Biotime has successfully established the mature medical marketing channels during the past years. With the leading technologies, Biotime aims to develop superior IVD products that provide better solutions for health care and benefit people all over the world. 

Our Vision 

 Become a leading POCT enterprise

Our Mission

Make science and technology serve health

Our Journey

• 2008 Set up in Xiamen, got ISO 13485                                                    
• 2010-2014 Full FIA solution, such as Hormone, Cardiac, Diabetes..
• 2017-2019 Top 20 POCT firm in China, got 40+ NMPA certifications
• 2020-2021 COVID-19 solution, Full POCT solution, got FDA EUA, TGA, ANVISA...
• 2022 Mergers & Acquisitions, increasing products and service

Our Technology Platforms

Our Team

Layout of global R&D centers (Singapore, the United States, Shenzhen, Shanghai, Chongqing, Hangzhou, Xiamen)

           

                      200+                                     30+                                            20+                                       

                              Engineers                                   Core intellectual property rights               Years of industry experience of engineers       

            9+                                                          800+                                                                 5+                         

         Products are the global pioneer                 Globalwise distributors                                               R&D Centers

         in fluorescent immuassay solution                                                           

Certification

100+ certifications including FDA(EUA), CE, ISO 13485, NGSP, Russia